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 Glossary  
Anisometropia – A condition in which the two eyes
have unequal refractive power so that the two eyes
are in different states of myopia.
Astigmatism – An optical defect causing blurred
images due to failure to focus a point object into a
sharp image on the retina.
Sensitive period – An early developmental period
that is particularly sensitive to development of
amblyopia.
Snellen acuity – Clarity of vision as measured by
eye care professionals using a chart called the
Snellen chart.
Strabismus – Misregistration or misalignment of the
images from the two eyes preventing the
development of binocular vision.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 What Is Amblyopia?
Amblyopia (from the Greek, amblyos – blunt; opia – vision)
is a developmental abnormality that results from physio-
logical alterations in the visual cortex and impairs form
vision. Amblyopia is clinically important because, aside
from refractive error, it is the most frequent cause of
vision loss in infants and young children, occurring natu-
rally in about 2–4% of the population; and it is of basic
interest because it reflects the neural impairment which
can occur when normal visual development is disrupted.
The damage produced by amblyopia is generally ex-
pressed in the clinical setting as a loss of visual acuity in
an apparently healthy eye, despite appropriate optical
correction; however, there is a great deal of evidence
showing that amblyopia results in a broad range of neural,
perceptual, and clinical abnormalities. Currently, there is
no positive diagnostic test for amblyopia. Instead, ambly-
opia is diagnosed by exclusion: in patients with conditions
such as strabismus and anisometropia, a diagnosis of
amblyopia is made through the exclusion of uncorrected
refractive error and underlying ocular pathology. Ambly-
opic patients (especially those with strabismic amblyopia)
often exhibit crowding problems, meaning they have bet-
ter visual acuity when letters are presented in isolation
than when they are presented in a line or a full chart.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Encyclopedia of Eye Clinically, crowding may be a useful sign to aid in the
diagnosis of amblyopia.Amblyopia Is a Significant Public Health
Problem
Amblyopia can easily be reversed or eliminatedwhen diag-
nosed and treated early in life. Thus, there is a premium
on early detection of amblyopia and its risk factors. It has
been estimated that perhaps as many as three-quarters of a
million preschoolers are at risk for amblyopia in the United
States, and roughly half of those may not be detected before
school age.Moreover, detection is likely to bemore delayed
in low socioeconomic areas. Improved vision screening and
access to treatment could, in principle, eliminate amblyopia
as a public health issue.Types of Amblyopia
Amblyopia comes in different sizes (degree of loss) and
flavors (types). The presence of amblyopia is almost
always associated with an early history of abnormal visual
experience: binocular misregistration (i.e., strabismus – a
turned eye), image degradation (high refractive error and
astigmatism, anisometropia), or, less commonly, form dep-
rivation (congenital cataract, ptosis). The severity of the
amblyopia appears to be associated with the degree of
imbalance between the two eyes (e.g., dense unilateral
cataract results in severe loss), and to the age at which
the amblyogenic factor occurred. Precisely how these
factors interact is as yet unknown, but it is evident that
different early visual experiences result in different func-
tional losses in amblyopia, and a significant factor that
distinguishes performance among amblyopes is the pres-
ence or absence of binocular function. Binocular function
is much more likely to be damaged when amblyopia
results from binocular misregistration (strabismus) than
from image blur (anisometropia).The Site(s) of Amblyopia
A longstanding question is the site of damage in ambly-
opia. Current opinion places the earliest functional phys-
iological abnormalities in cortical area V1. Exhaustive
anatomical and physiological experiments failed to find
retinal alterations in monkeys reared with experimen-
tally induced amblyopia. These same animals had marked
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 abnormalities in V1. Moreover, although human electro-
retinogram (ERG) studies are equivocal, after optimizing
optical focus, fixation alignment, and fixation stability,
Robert Hess and colleagues found no pattern ERG deficit
in deep amblyopes, in a spatial frequency range where
there were obvious psychophysical deficits for the same
stimuli. Although it is possible that retrograde degenera-
tion may affect the lateral geniculate nucleus (where there
is some shrinkage of the cells in the parvocellular layers)
and retina, it seems unlikely that these effects contribute
significantly to the behavioral losses. In contrast, ambly-
opia results in profound alterations in V1 both in cats and
monkeys. In monkeys, visual deprivation (via lid suture)
leads to a massive loss of neurons in V1 that can be driven
by the deprived eye. Experimentally induced blur during
development leads to a selective loss of V1 neurons tuned
to high spatial frequencies and the spatial tuning of neu-
rons may be markedly different when tested through the
two eyes. Experimentally induced strabismus disrupts the
binocular connections of cortical neurons. It is difficult to
draw distinctions based on the type of rearing from the
physiology, because the effects of abnormal visual experi-
ence are complicated by the onset, duration, and depth of
deprivation; however, there is evidence that the physio-
logical deficits in amblyopia do not fully explain the
behavioral losses (in the same monkeys), suggesting that
there may be deficits downstream from V1.
The most dramatic changes in V1 involve alterations in
binocularity. Specifically, neurons that appeared to be
monocular often demonstrate clear binocular interactions
during dichoptic stimulation. In strabismic (prism-reared)
monkeys, there is marked binocular suppression during
dichoptic stimulation suggesting that inhibitory connec-
tions are less susceptible to the effects of strabismus than
excitatory connections. Interestingly, even very brief per-
iods (just 3 days) of prism-induced strabismus at the
height of the critical period (4 weeks in monkeys, which
translates to about 4months in humans) increased the
prevalence of V1 neurons that exhibited binocular sup-
pression without altering their sensitivity to interocular
spatial phase disparity. This result suggests that the ear-
liest change in V1 is increased binocular suppression and,
importantly, that the suppression originates at a site
downstream from where information from the two eyes
is first combined.
Very much less is known about the physiological effects
of amblyopia on visual areas downstream from V1. Brain-
imaging studies using positron emission tomography and
functional magnetic resonance imaging show a clear deficit
in V1, and several studies have also found deficits in other
areas (e.g., V2). However, it is difficult to discern whether
these downstream losses are simply a pass-through effect
from V1 or whether the V1 losses are amplified down-
stream. However, several imaging and psychophysical
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Encyclopedia of Eye (2studies are consistent with the idea that the abnormali-
ties in V1 are amplified in V2 and possibly beyond. These
studies show losses in second-order detection global form
and motion integration, symmetry detection, and counting.Sensitive Periods for the Development
of Amblyopia
Clinicians are well aware that amblyopia does not develop
after 6–8 years of age, suggesting that there is a sensitive
period for the development of amblyopia; however, in
humans with naturally occurring amblyopia, the age of
onset of the amblyogenic condition(s) is difficult to ascer-
tain, and the effects of intervention combine to make
it difficult to obtain a clear picture of the natural history
of amblyopia development. Thus, much of our current
understanding of the development of amblyopia accrues
from animal studies, and from retrospective studies of
clinical records. Technological improvements in infant
testing have also provided more direct data on the devel-
opment of naturally occurring amblyopia in humans and
monkeys. All of these studies provide strong evidence for
amblyopia induced by early deprivation.
While the upper limit for susceptibility of binocular
interactions (binocular summation and stereopsis) is not
yet certain, it appears to be later than that for acuity or
contrast sensitivity in monkeys, and may extend to at least
7 or 8 years (and possibly more) in humans. Psychophysi-
cal studies of interocular transfer in humans with a history
of strabismus provide an indirect estimate of the period of
susceptibility of binocular connections. The results of
both studies suggest that binocular connections are highly
vulnerable during the first 18months of life, and remain
susceptible to the effects of strabismus until at least age
7 years.Traditional Treatment of Amblyopia
For centuries, the primary treatment for amblyopia has
consisted of patching or penalizing the fellow preferred
eye, thus forcing the brain to use the weaker amblyopic
eye. Typically, patients with mild to moderate amblyopia
are prescribed complete occlusion for 2–6 waking hours
per day, over several months to more than a year. Patients
with moderate to severe amblyopia are often prescribed
6–10 h or more a day, and some clinicians recommend
more aggressive full-time occlusion for severe amblyopia.
As reported in a recent large-scale clinical study of chil-
dren (3–8 years of age), the dose–response rate for occlu-
sion is approximately 0.1 log unit (1 chart line) per 120 h
of occlusion, and the treatment efficacy is 3–4 logMAR
lines. The dose–response curve appears to plateau only
after 100–400 h. The treatment outcome is dependent on
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 occlusion dose, the depth of amblyopia, binocular status,
fixation pattern, the age at presentation, and patient com-
pliance. Recent clinical studies suggest that atropine
penalization may be just as effective as patching.
The notion that there is a sensitive period (or periods)
for the development of amblyopia has often been taken to
indicate that there is also a critical period for the treat-
ment of amblyopia. This concept grew out of the work of
Claude Worth in 1903. Worth suggested that the presence
of a sensory obstacle (e.g., unilateral strabismus) arrested
the development of visual acuity (amblyopia of arrest), so
that the patient’s acuity remained at the level achieved at
the time of onset of strabismus. In this view, the depth of
amblyopia is a direct function of the age of onset of the
sensory obstacle. Worth further suggested that, if ambly-
opia of arrest were allowed to persist, amblyopia of
extinction could occur as a result of binocular inhibition.
In Worth’s view, only this extra loss of sensory function
(i.e., the amblyopia of extinction) could be recovered by
treatment. Although this latter notion is open to question
in the light of present knowledge, the ideas of Worth have
had a powerful influence upon both clinicians and basic
scientists. Many of our currently held concepts of ambly-
opia, such as plasticity, sensitive periods, and abnormal
binocular interaction, were already described more than a
century ago, and gained currency with the work of Hubel
and Wiesel in 1970 and the many anatomical and physio-
logical studies that followed. Consequently, while ambly-
opia can often be reversed when treated early, treatment
is generally not undertaken in older children and adults.
Below we consider both experimental and clinical evidence
for plasticity in the adult visual system that calls into
question the notion of a sensitive period for treatment.
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Figure 1 The postnatal development of visual function.
Cartoon illustrating visual functions (sehfunktion) developing at
somewhat different rates, while the developmental potential
(entwicklungspotenz, in the lower panel) dissipates over the years
(Jahre). Reproduced from Teller, D. Y. and Movshon, J. A. (1986)
Visual Development. Vision Research 26: 1483–1506.
 
 
 
 
 
 Clinical Studies
It is often stated that humans with amblyopia cannot be
treated beyond a certain age; however, a review of the
literature suggests otherwise. Recent clinical trials suggest
that in children, 2 h of patching per day may be just as
effective as 6 h per day. Moreover, treatment may be just as
effective in older (13–17 years) patients who have not been
previously treated as in younger (7–12 years) children.
Plasticity in adults with amblyopia is also dramatically
evident in the report of amblyopic patients whose visual
acuity spontaneously improved in the wake of visual loss
due to macular degeneration in the fellow eye. There are
also reports suggesting that some adult amblyopes recover
vision in their amblyopic eye following loss of vision in their
fellow (nonamblyopic) eye. These studies are consistentwith
the notion that the connections from the amblyopic eye may
be suppressed rather than destroyed. Loss of the fellow eye
would allow these existing connections to be unmasked, as
occurs in adult cats with retinal lesions (Figure 1).
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Encyclopedia of Eye Experimental Treatment of Amblyopia Beyond
the Sensitive Period
Adults are capable of improving performance on sensory
tasks through repeated practice or perceptual learning
(‘yes, you can teach old dogs new tricks!’), and this learn-
ing is considered to be a form of neural plasticity that also
has consequences in the cortex. Specifically, in adults with
normal vision, practice can improve performance on a
variety of visual tasks, and this learning can be quite
specific (to the trained task, orientation, eye, etc.). Inter-
estingly, similar neural plasticity exists in the visual sys-
tem of adults with naturally occurring amblyopia due to
anisometropia and/or strabismus, suggesting that percep-
tual learning may be a useful approach for amblyopia
treatment. Perceptual learning can improve visual func-
tions in amblyopia on a wide range of tasks, including:
Vernier acuity, positional acuity, contrast sensitivity, and
letter identification. Practicing each of these tasks results
in improved performance on the practiced task.
The specificity of perceptual learning noted above
poses some interesting difficulties. If the improvement
following practice was solely limited to the trained stim-
ulus, condition and task, then the type of plasticity docu-
mented here would have very limited (if any) therapeutic
value for amblyopia, since amblyopia is defined primarily
on the basis of reduced Snellen acuity. Importantly, per-
ceptual learning of many tasks (e.g., Vernier acuity, position
discrimination, contrast sensitivity) appears to transfer, at
least in part, to improvements in Snellen acuity, as does
practicing contrast detection. In addition to visual acuity
improvement, other degraded visual functions such as
stereoacuity and visual counting improve as well.(2010), vol. 3, pp. 63-66 
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Figure 2 Improvement in positional acuity (solid circles) and
Snellen acuity (open circles) of a severe juvenile amblyope
(observer AL, 8.8 years old, with unilateral strabismus). The
triangle shows the improvement based on occlusion alone. The
gray line shows the improvement based on occlusion alone
(OT: occlusion therapy) in 2 amblyopes (aged 6–8) with acuities
similar to that of AL. Replotted from Li et al., 2007; Stewart et al.,
2004, 2005, 2007.
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 Perceptual Learning as a Clinical Tool for
Treating Amblyopia
Occlusion therapy is the gold standard method for treat-
ing amblyopia. In all previous perceptual learning studies,
the subjects are occluded while performing the visual
task, so it is reasonable to ask whether active perceptual
learning actually provides an added benefit over occlu-
sion alone. Recent work suggests that occlusion plus per-
ceptual learning may be more effective than occlusion
alone (Figure 2). Combining occlusion with perceptual
learning may be a useful method for obtaining the optimal
treatment outcome in the shortest possible time. Eliminat-
ing or reducing the need to wear an eye patch in public
would eliminate, or at the very least reduce, the emotional
stress that often accompanies occlusion therapy.
Over the centuries, there have been numerous attempts
to increase the effectiveness of treatment. These attempts
have a long and chequered history, ranging from the sub-
lime to the ridiculous, and include: subcutaneous injection
of strychnine, electrical stimulation of the retina and optic
nerve, flashing lights, red filters and rotating gratings,
administration of Levodopa/Carbidopa and shocks to the
brain via transcranial magnetic stimulation. Few were
subjected to rigorous scrutiny, and those that were often
failed to stand up to it. Thus, any promising new method
should be examined critically and there is a clear need for
careful controlled studies.
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